{"article_title": "Is It Time to Buy Galena? -- The Motley Fool", "article_keywords": ["fool", "shareholders", "buy", "rumors", "variety", "motley", "price", "share", "video", "williamson", "galena", "health", "stockin", "stock"], "article_url": "http://www.fool.com/investing/general/2014/06/10/is-it-time-to-buy-galena.aspx", "article_text": "Galena Biopharma (NASDAQ:GALE) shareholders have had a rough 2014 so far, with the stock dipping over 50% from its highs just north of $7 to a recent share price of just over $3. The stock has been plagued by rumors and allegations of share price manipulation and a variety of other issues. But let's leave the rumors aside and focus on the fundamentals and the pipeline, the actual business behind the share price.\n\nSo is it time to buy the stock?\n\nIn the video below, from Market Checkup, the Motley Fool's health care-focused investing show, health care analysts Michael Douglass and David Williamson answer.", "article_metadata": {"publish_time": "18:11", "description": "Leaving aside the rumors and everything else, is the stock a good opportunity for biotech investors?", "ResponsiveALP": "1Ses_2things-v-single_2-things_50", "author": "Michael Douglass and Dave Williamson", "promo": "Leaving aside the rumors and everything else, is the stock a good opportunity for biotech investors?", "twitter": {"title": "Is It Time to Buy Galena? --  The Motley Fool", "description": "Leaving aside the rumors and everything else, is the stock a good opportunity for biotech investors?", "site": "@themotleyfool"}, "msvalidate.01": "8D40D58712924715BAA79D135A6C8DDA", "og": {"site_name": "The Motley Fool", "description": "Leaving aside the rumors and everything else, is the stock a good opportunity for biotech investors?", "title": "Is It Time to Buy Galena? --  The Motley Fool", "url": "http://www.fool.com/investing/general/2014/06/10/is-it-time-to-buy-galena.aspx", "image": "https://g.foolcdn.com/image/?url=http%3A%2F%2Fg.foolcdn.com%2Fassets%2Fimages%2Ffool%2Ftmf-logo.png&h=630&w=1200&op=resize", "type": "article"}, "headline": "Is It Time to Buy Galena?", "fb": {"admins": 50808187550, "page_id": 7240312795, "app_id": 50808187550}, "bureau": "usmf-health-care", "STORY_UID": "edff6922-f0dd-11e3-bea6-0050569d4be0", "pitch": 681, "date": "2014-06-10T22:11:00Z", "gsa_date": "2014 06 10", "tickers": "GALE", "viewport": "width=device-width, initial-scale=1.0, maximum-scale=1.0"}, "_id": "\"57477af36914bd0286fca284\"", "article_summary": "But let's leave the rumors aside and focus on the fundamentals and the pipeline, the actual business behind the share price.\nIn the video below, from Market Checkup, the Motley Fool's health care-focused investing show, health care analysts Michael Douglass and David Williamson answer.\nThe stock has been plagued by rumors and allegations of share price manipulation and a variety of other issues.\nGalena Biopharma (NASDAQ:GALE) shareholders have had a rough 2014 so far, with the stock dipping over 50% from its highs just north of $7 to a recent share price of just over $3.\nSo is it time to buy the stock?"}